Heart Rhythm, ISSN 1547-5271, 2016
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 9, pp. 961 - 962
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 12, pp. 1217 - 1226
Abstract Background Although the prognostic value of findings from cardiac magnetic resonance (CMR) imaging has been established in single-center center...
Cardiovascular | Internal Medicine | prognosis | magnetic resonance imaging | myocardial infarction | VENTRICULAR EJECTION FRACTION | MICROVASCULAR OBSTRUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | HEMORRHAGE | CARDIOVASCULAR MAGNETIC-RESONANCE | RISK STRATIFICATION | SIZE | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | INTRACORONARY | INTRAVENOUS BOLUS ABCIXIMAB | Myocardial Infarction - diagnosis | Single-Blind Method | Myocardial Infarction - mortality | Prognosis | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Magnetic Resonance Imaging, Cine - methods | Female | Myocardial Infarction - physiopathology | Aged | Sects | Heart attack | Confidence intervals | Heart attacks | Multivariate analysis | Angioplasty | Laboratories | Risk assessment
Cardiovascular | Internal Medicine | prognosis | magnetic resonance imaging | myocardial infarction | VENTRICULAR EJECTION FRACTION | MICROVASCULAR OBSTRUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | HEMORRHAGE | CARDIOVASCULAR MAGNETIC-RESONANCE | RISK STRATIFICATION | SIZE | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | INTRACORONARY | INTRAVENOUS BOLUS ABCIXIMAB | Myocardial Infarction - diagnosis | Single-Blind Method | Myocardial Infarction - mortality | Prognosis | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Magnetic Resonance Imaging, Cine - methods | Female | Myocardial Infarction - physiopathology | Aged | Sects | Heart attack | Confidence intervals | Heart attacks | Multivariate analysis | Angioplasty | Laboratories | Risk assessment
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016
Abstract Cigarette smokers with ST-segment elevation myocardial infarction (STEMI) may present different response to potent antithrombotic therapy compared...
Cardiovascular
Cardiovascular
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 5, pp. 481 - 482
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9905, pp. 1638 - 1645
Summary Background In current international guidelines the recommendation for intra-aortic balloon pump (IABP) use has been downgraded in cardiogenic shock...
Internal Medicine | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | EARLY REVASCULARIZATION | MANAGEMENT | TASK-FORCE | ESC | PREDICTORS | GUIDELINES | ASSOCIATION | TRENDS | Myocardial Infarction - mortality | Follow-Up Studies | Shock, Cardiogenic - complications | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Intra-Aortic Balloon Pumping - mortality | Myocardial Revascularization | Myocardial Infarction - complications | Myocardial Infarction - therapy | Time Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Care and treatment | Intra-aortic balloon counterpulsation | Patient outcomes | Heart attack | Cardiovascular disease | Heart attacks | Drug therapy | Mortality | Coronary vessels | Quality of life
Internal Medicine | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | EARLY REVASCULARIZATION | MANAGEMENT | TASK-FORCE | ESC | PREDICTORS | GUIDELINES | ASSOCIATION | TRENDS | Myocardial Infarction - mortality | Follow-Up Studies | Shock, Cardiogenic - complications | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Intra-Aortic Balloon Pumping - mortality | Myocardial Revascularization | Myocardial Infarction - complications | Myocardial Infarction - therapy | Time Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Care and treatment | Intra-aortic balloon counterpulsation | Patient outcomes | Heart attack | Cardiovascular disease | Heart attacks | Drug therapy | Mortality | Coronary vessels | Quality of life
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015
Abstract It is unknown whether the occurrence of ST-elevation myocardial infarction (STEMI) at a younger age is associated with differences in myocardial...
Cardiovascular
Cardiovascular
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 22, pp. 2470 - 2479
Objectives The aim of the study was to determine the prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic...
Cardiovascular | Internal Medicine | myocardial salvage | magnetic resonance imaging | cardiovascular magnetic resonance | prognosis | myocardial infarction | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | SIZE | RANDOMIZED-TRIAL | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | THERAPY | AREA | ST-SEGMENT ELEVATION | PRIMARY ANGIOPLASTY | Myocardial Infarction - diagnosis | Severity of Illness Index | Myocardial Infarction - mortality | Prospective Studies | Follow-Up Studies | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Probability | Male | Myocardium - pathology | Treatment Outcome | Chi-Square Distribution | Myocardial Infarction - therapy | Magnetic Resonance Imaging, Cine - methods | Angioplasty, Balloon, Coronary - mortality | Coronary Angiography - methods | Time Factors | Statistics, Nonparametric | Survival Analysis | Electrocardiography | Female | Aged | Cardiology | Heart attack | Diagnosis | Hypertension | Confidence intervals | Enzymes | Heart attacks | Salvage | Angioplasty | Risk assessment | Regression analysis | Diabetes
Cardiovascular | Internal Medicine | myocardial salvage | magnetic resonance imaging | cardiovascular magnetic resonance | prognosis | myocardial infarction | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | SIZE | RANDOMIZED-TRIAL | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | THERAPY | AREA | ST-SEGMENT ELEVATION | PRIMARY ANGIOPLASTY | Myocardial Infarction - diagnosis | Severity of Illness Index | Myocardial Infarction - mortality | Prospective Studies | Follow-Up Studies | Risk Assessment | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Probability | Male | Myocardium - pathology | Treatment Outcome | Chi-Square Distribution | Myocardial Infarction - therapy | Magnetic Resonance Imaging, Cine - methods | Angioplasty, Balloon, Coronary - mortality | Coronary Angiography - methods | Time Factors | Statistics, Nonparametric | Survival Analysis | Electrocardiography | Female | Aged | Cardiology | Heart attack | Diagnosis | Hypertension | Confidence intervals | Enzymes | Heart attacks | Salvage | Angioplasty | Risk assessment | Regression analysis | Diabetes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 13, pp. 1342 - 1342
Journal Article
10.
Full Text
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 15, pp. 1913 - 1920
Abstract Background Mortality in cardiogenic shock (CS) remains high. Early risk stratification is crucial to make adequate treatment decisions. Objectives...
Cardiovascular | Internal Medicine | mortality | percutaneous coronary intervention | acute coronary syndrome | prognosis | TIMI flow grade | risk score | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | II-TRIAL | DEATH | INTRAAORTIC BALLOON COUNTERPULSATION | PREDICTORS | REGISTRY | Intra-Aortic Balloon Pumping - methods | Risk Assessment - methods | Shock, Cardiogenic - therapy | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Shock, Cardiogenic - mortality | Thrombolytic Therapy - statistics & numerical data | Male | Myocardial Infarction - complications | Outcome and Process Assessment (Health Care) | Shock, Cardiogenic - etiology | Percutaneous Coronary Intervention - methods | Thrombolytic Therapy - methods | Female | Percutaneous Coronary Intervention - statistics & numerical data | Aged | Intra-Aortic Balloon Pumping - statistics & numerical data | Research Design | Germany | Cardiology | Cardiogenic shock | Emergency medicine | Myocardial infarction | Heart | Shock | Heart attacks | Renal function | Laboratories | Medical services | Clinical trials | Insertion | Population studies | Scoring | Glucose | Variables | Ethics | Capes (landforms) | Etiology | Quality | Risk assessment | Electrocardiography | Aorta | Mathematical models | Heart diseases | Resuscitation | Age | Statistical analysis | Catheterization | Cut-off | Categories | Diabetes mellitus | Health risks | Coronary artery | Hazards | Congestion | Regression analysis | Injection | Statistical tests | Patients | Hypotension | Plotting | Studies | Life span | Predictions | Biomarkers | Death | Intubation | Diabetes | Kidney transplantation
Cardiovascular | Internal Medicine | mortality | percutaneous coronary intervention | acute coronary syndrome | prognosis | TIMI flow grade | risk score | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | II-TRIAL | DEATH | INTRAAORTIC BALLOON COUNTERPULSATION | PREDICTORS | REGISTRY | Intra-Aortic Balloon Pumping - methods | Risk Assessment - methods | Shock, Cardiogenic - therapy | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Shock, Cardiogenic - mortality | Thrombolytic Therapy - statistics & numerical data | Male | Myocardial Infarction - complications | Outcome and Process Assessment (Health Care) | Shock, Cardiogenic - etiology | Percutaneous Coronary Intervention - methods | Thrombolytic Therapy - methods | Female | Percutaneous Coronary Intervention - statistics & numerical data | Aged | Intra-Aortic Balloon Pumping - statistics & numerical data | Research Design | Germany | Cardiology | Cardiogenic shock | Emergency medicine | Myocardial infarction | Heart | Shock | Heart attacks | Renal function | Laboratories | Medical services | Clinical trials | Insertion | Population studies | Scoring | Glucose | Variables | Ethics | Capes (landforms) | Etiology | Quality | Risk assessment | Electrocardiography | Aorta | Mathematical models | Heart diseases | Resuscitation | Age | Statistical analysis | Catheterization | Cut-off | Categories | Diabetes mellitus | Health risks | Coronary artery | Hazards | Congestion | Regression analysis | Injection | Statistical tests | Patients | Hypotension | Plotting | Studies | Life span | Predictions | Biomarkers | Death | Intubation | Diabetes | Kidney transplantation
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9819, pp. 923 - 931
Summary Background Intracoronary administration of an abciximab bolus during a primary percutaneous coronary intervention results in a high local drug...
Internal Medicine | RECOVERY | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | MULTICENTER | DESIGN | CLOPIDOGREL | PROFILE | DOUBLE-BLIND | PRIMARY ANGIOPLASTY | LEFT-VENTRICULAR FUNCTION | Injections, Intravenous | Humans | Middle Aged | Male | Coronary Vessels | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Female | Aged | Stents | Injections, Intra-Arterial | Abciximab | Research | Drug therapy | Health aspects | Heart attack | Heart failure | Myocardial infarction | Intervention | Drug delivery systems | Intravenous administration | Heart attacks | Angioplasty | Safety measures | Colleges & universities | Congestive heart failure | Patients | Thrombolysis | Infusion | Elevation | Randomization | Perfusion | Monoclonal antibodies | Infarction | Intravenous infusion | Drug dosages | Veins & arteries | Clinical trials
Internal Medicine | RECOVERY | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | MULTICENTER | DESIGN | CLOPIDOGREL | PROFILE | DOUBLE-BLIND | PRIMARY ANGIOPLASTY | LEFT-VENTRICULAR FUNCTION | Injections, Intravenous | Humans | Middle Aged | Male | Coronary Vessels | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Female | Aged | Stents | Injections, Intra-Arterial | Abciximab | Research | Drug therapy | Health aspects | Heart attack | Heart failure | Myocardial infarction | Intervention | Drug delivery systems | Intravenous administration | Heart attacks | Angioplasty | Safety measures | Colleges & universities | Congestive heart failure | Patients | Thrombolysis | Infusion | Elevation | Randomization | Perfusion | Monoclonal antibodies | Infarction | Intravenous infusion | Drug dosages | Veins & arteries | Clinical trials
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2014, Volume 7, Issue 9, pp. 930 - 939
Abstract The aim of this study was to evaluate the value of microvascular obstruction (MO) and infarct size as a percentage of left ventricular mass (IS%LV),...
Cardiovascular | infarct size | cardiac magnetic resonance | prognosis | microvascular obstruction | myocardial infarction | Myocardial infarction | Microvascular obstruction | Infarct size | Prognosis | Cardiac magnetic resonance | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | DETERMINANTS | CARDIAC MAGNETIC-RESONANCE | NO-REFLOW PHENOMENON | RECOVERY | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PRIMARY ANGIOPLASTY | Predictive Value of Tests | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Heart Failure - physiopathology | Male | Microcirculation | Myocardial Infarction - therapy | Time Factors | Myocardial Infarction - pathology | Female | Myocardial Infarction - physiopathology | No-Reflow Phenomenon - physiopathology | Heart Ventricles - pathology | Heart Failure - mortality | Coronary Circulation | Myocardial Infarction - diagnosis | Risk Assessment | Risk Factors | Myocardium - pathology | No-Reflow Phenomenon - diagnosis | Treatment Outcome | Magnetic Resonance Imaging | No-Reflow Phenomenon - pathology | Heart Ventricles - physiopathology | Aged | Percutaneous Coronary Intervention - adverse effects | Life Sciences | Bioengineering | Nuclear medicine
Cardiovascular | infarct size | cardiac magnetic resonance | prognosis | microvascular obstruction | myocardial infarction | Myocardial infarction | Microvascular obstruction | Infarct size | Prognosis | Cardiac magnetic resonance | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | DETERMINANTS | CARDIAC MAGNETIC-RESONANCE | NO-REFLOW PHENOMENON | RECOVERY | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PRIMARY ANGIOPLASTY | Predictive Value of Tests | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Heart Failure - physiopathology | Male | Microcirculation | Myocardial Infarction - therapy | Time Factors | Myocardial Infarction - pathology | Female | Myocardial Infarction - physiopathology | No-Reflow Phenomenon - physiopathology | Heart Ventricles - pathology | Heart Failure - mortality | Coronary Circulation | Myocardial Infarction - diagnosis | Risk Assessment | Risk Factors | Myocardium - pathology | No-Reflow Phenomenon - diagnosis | Treatment Outcome | Magnetic Resonance Imaging | No-Reflow Phenomenon - pathology | Heart Ventricles - physiopathology | Aged | Percutaneous Coronary Intervention - adverse effects | Life Sciences | Bioengineering | Nuclear medicine
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 19, pp. 2148 - 2150
Importantly, there was a clear divergence of mortality curves <=2 months after initial presentation, which implies that arrhythmias are of higher prognostic...
Cardiovascular | Internal Medicine | MAGNETIC-RESONANCE | CARDIAC & CARDIOVASCULAR SYSTEMS | Arrhythmias, Cardiac - epidemiology | Prevalence | Survival Rate - trends | Global Health | Humans | Takotsubo Cardiomyopathy - mortality | Female | Male | Aged | Arrhythmias, Cardiac - etiology | Arrhythmias, Cardiac - physiopathology | Takotsubo Cardiomyopathy - complications | Arrhythmia | Prevalence studies (Epidemiology) | Confidence intervals | Cardiac arrhythmia | Heart attacks | Cardiomyopathy | Mortality | Medical prognosis | Gangrene
Cardiovascular | Internal Medicine | MAGNETIC-RESONANCE | CARDIAC & CARDIOVASCULAR SYSTEMS | Arrhythmias, Cardiac - epidemiology | Prevalence | Survival Rate - trends | Global Health | Humans | Takotsubo Cardiomyopathy - mortality | Female | Male | Aged | Arrhythmias, Cardiac - etiology | Arrhythmias, Cardiac - physiopathology | Takotsubo Cardiomyopathy - complications | Arrhythmia | Prevalence studies (Epidemiology) | Confidence intervals | Cardiac arrhythmia | Heart attacks | Cardiomyopathy | Mortality | Medical prognosis | Gangrene
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 13, pp. 1447 - 1454
Objectives The aim of the AIDA STEMI (Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction) cardiac magnetic resonance (CMR) substudy was to...
Cardiovascular | Internal Medicine | glycoprotein IIb/IIIa inhibition | infarction | infarct size | cardiac magnetic resonance imaging | angioplasty | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DETERMINANTS | RATIONALE | CARDIOVASCULAR MAGNETIC-RESONANCE | SIZE | INHIBITORS | PRIMARY ANGIOPLASTY | BENEFITS | Transluminal angioplasty | Sects | Abciximab | Heart attack | Cardiology | Heart failure | Heart attacks | Angioplasty | Laboratories | Mortality | Regression analysis | Multivariate analysis | Hemorrhage | Studies | Confidence intervals | Variables | Coronary vessels
Cardiovascular | Internal Medicine | glycoprotein IIb/IIIa inhibition | infarction | infarct size | cardiac magnetic resonance imaging | angioplasty | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DETERMINANTS | RATIONALE | CARDIOVASCULAR MAGNETIC-RESONANCE | SIZE | INHIBITORS | PRIMARY ANGIOPLASTY | BENEFITS | Transluminal angioplasty | Sects | Abciximab | Heart attack | Cardiology | Heart failure | Heart attacks | Angioplasty | Laboratories | Mortality | Regression analysis | Multivariate analysis | Hemorrhage | Studies | Confidence intervals | Variables | Coronary vessels
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2012, Volume 5, Issue 5, pp. 513 - 524
Objectives The goal of this study was to assess the diagnostic performance of cardiac magnetic resonance (CMR) compared with endomyocardial biopsy in patients...
Cardiovascular | endomyocardial biopsy | myocardial inflammation | cardiac magnetic resonance | myocarditis | DEFINITION | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR MAGNETIC-RESONANCE | PATHOLOGY | SOCIETY | CARDIAC MR | HYPERTROPHIC CARDIOMYOPATHY | TASK-FORCE | INFLAMMATION | TROPONIN-T | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Myocarditis - diagnosis | Edema, Cardiac - diagnosis | Sensitivity and Specificity | Edema, Cardiac - pathology | Adult | Female | Acute Disease | Myocarditis - complications | Hyperemia - etiology | Myocardium - pathology | Chi-Square Distribution | Hyperemia - diagnosis | Magnetic Resonance Imaging | Myocarditis - virology | Contrast Media | Biopsy | Fibrosis | Aged | Myocarditis - pathology | Edema, Cardiac - etiology | Chronic Disease | Germany
Cardiovascular | endomyocardial biopsy | myocardial inflammation | cardiac magnetic resonance | myocarditis | DEFINITION | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR MAGNETIC-RESONANCE | PATHOLOGY | SOCIETY | CARDIAC MR | HYPERTROPHIC CARDIOMYOPATHY | TASK-FORCE | INFLAMMATION | TROPONIN-T | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Myocarditis - diagnosis | Edema, Cardiac - diagnosis | Sensitivity and Specificity | Edema, Cardiac - pathology | Adult | Female | Acute Disease | Myocarditis - complications | Hyperemia - etiology | Myocardium - pathology | Chi-Square Distribution | Hyperemia - diagnosis | Magnetic Resonance Imaging | Myocarditis - virology | Contrast Media | Biopsy | Fibrosis | Aged | Myocarditis - pathology | Edema, Cardiac - etiology | Chronic Disease | Germany
Journal Article
16.
Full Text
Reply
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 2, pp. 222 - 222
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 164, Issue 5, pp. 706 - 714
Background Circulating microRNAs (miRs) have emerged as potential diagnostic markers in patients with myocardial infarction. Previous studies, however, were...
Cardiovascular | BIOMARKERS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | PLASMA | CARDIOVASCULAR MAGNETIC-RESONANCE | DISEASE | TARGETS | SERUM | Myocardial Infarction - diagnosis | Myocardial Infarction - blood | Predictive Value of Tests | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Biomarkers - blood | Magnetic Resonance Imaging, Cine | Reverse Transcriptase Polymerase Chain Reaction | Coronary Angiography | Heart Conduction System - physiopathology | Electrocardiography | Female | Myocardial Infarction - physiopathology | Aged | MicroRNAs - blood | MicroRNA | Cardiac patients | Heart attack | Enzymes | Heart attacks | MicroRNAs | Biomarkers | Regression analysis | Cardiology | Gene expression
Cardiovascular | BIOMARKERS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | PLASMA | CARDIOVASCULAR MAGNETIC-RESONANCE | DISEASE | TARGETS | SERUM | Myocardial Infarction - diagnosis | Myocardial Infarction - blood | Predictive Value of Tests | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Biomarkers - blood | Magnetic Resonance Imaging, Cine | Reverse Transcriptase Polymerase Chain Reaction | Coronary Angiography | Heart Conduction System - physiopathology | Electrocardiography | Female | Myocardial Infarction - physiopathology | Aged | MicroRNAs - blood | MicroRNA | Cardiac patients | Heart attack | Enzymes | Heart attacks | MicroRNAs | Biomarkers | Regression analysis | Cardiology | Gene expression
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 6, pp. 938 - 945
Background In current guidelines, intraaortic balloon pumping (IABP) is considered a class 1 indication in cardiogenic shock complicating acute myocardial...
Cardiovascular | VENTRICULAR ASSIST DEVICES | SURGERY | PERCUTANEOUS CORONARY INTERVENTION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | OUTCOMES | TRENDS | Myocardial Infarction - complications | Shock, Cardiogenic - etiology | Prognosis | Prospective Studies | Shock, Cardiogenic - therapy | Humans |
Cardiovascular | VENTRICULAR ASSIST DEVICES | SURGERY | PERCUTANEOUS CORONARY INTERVENTION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | OUTCOMES | TRENDS | Myocardial Infarction - complications | Shock, Cardiogenic - etiology | Prognosis | Prospective Studies | Shock, Cardiogenic - therapy | Humans |